Uncategorized

QureBio to Speak at ACCESS ASIA Partnering Forum | Online Showcase

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Dr. Xiangdong Qu, Founder and General Manager of QureBio, will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About  QureBio

Qure Biotechnology (QureBio), founded in 2017 and headquartered in Shanghai, is a biopharmaceutical company developing innovative antibody and protein therapeutics with a focus on oncology, autoimmune diseases, and inflammatory disorders. Leveraging proprietary bispecific and multispecific antibody platforms, QureBio has built a robust pipeline to address major unmet medical needs. Lead asset Q-1802, a first-in-class CLDN18.2/PD-L1 bispecific antibody, is in Phase 2 with promising efficacy in advanced gastric and gastroesophageal junction cancers, alongside encouraging early signals in pancreatic cancer.

About the Speaker

Dr. Xiangdong Qu serves as Founder & General Manager, bringing over two decades of biopharmaceutical R&D experience across leading global companies, including Hengrui Pharmaceutical, Amgen, and Lilly. He has led projects in oncology, immunology, metabolism, cardiovascular, and neuroscience, with several products successfully launched or advancing to Phase III clinical trials. As a first/second inventor on multiple drug targets such as PD-1, IL-15, PD-L1, PCSK9, and TSLP, Dr. Qu is credited with three marketed drugs and is recognized for his expertise in protein engineering, antibody technology, and leadership in both small and large research teams.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/

Contact Us

To register for ACCESS ASIA Online Showcase, please visit: Register Here – ACCESS ASIA Partnering Forum 2025

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com